Find a Provider

Lee Hartner, MD

Lee Hartner, MD Physician

Director, GI-CREP Program
Clinical Associate Professor of Medicine

Dr. Hartner is a Penn Medicine employed physician.

Clinical Specialties

Specialties:

  • Medicine
    • Hematology
    • Medical Oncology

Programs & Services:

  • Cancer
    • Anal Cancer
    • Bone Marrow Transplant and Stem Cell Transplant Program
    • Brain Metastasis
    • Brain Tumors
    • Breast Cancer
    • Colon Cancer
    • Gastrointestinal Carcinoid Tumor
    • Leukemia
    • Liver Cancer
    • Oropharyngeal Cancer
    • Pituitary Cancer
    • Prostate Cancer
    • Rectal Cancer
    • Small Intestine Cancer
    • Spinal Cord Cancer
    • Stomach (Gastric) Cancer
    • Testicular Cancer
    • Thymus Cancer
    • Urethral Cancer
  • Hematology-Oncology
    • Classical (Non-Malignant) Hematology Program

Board Certification:

  • Hematology, 2004
  • Hospice and Palliative Medicine, 2010
  • Internal Medicine, 1997
  • Medical Oncology, 2005

Conditions & Treatments:

  • Anal Cancer
  • Bile Duct Cancer
  • Bladder Cancer
  • Blood Cancer
  • Brain Metastasis
  • Brain Tumors
  • Colon Cancer
  • Esophageal Cancer
  • Gallbladder Cancer
  • Gastrointestinal Carcinoid Tumor
  • Kidney Cancer
  • Laryngeal Cancer
  • Liver Cancer
  • Mouth Cancer
  • Nasal Cancer
  • Neuroendocrine Tumors
  • Oral Cancer
  • Oropharyngeal Cancer
  • Pancreatic Cancer
  • Penile Cancer
  • Prostate Cancer
  • Rectal Cancer
  • Sinus Cancer
  • Small Intestine Cancer
  • Spinal Cord Cancer
  • Stomach (Gastric) Cancer
  • Testicular Cancer
  • Throat Cancer
  • Thyroid Cancer
  • Tongue Cancer

Clinical Interests

Bone and Soft Tissue Sarcoma
Head and Neck Cancer

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Care
  • Rail Road Medicare / Palmetto GBA
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: Tufts University School of Medicine
Residency: NewYork-Presbyterian/Weill Cornell Medical Center
Fellowship: Tufts - New England Medical Center

Memberships

American College of Physicians, National American Society of Clinical Oncology, National American Society of Hematology, National Connective Tissue Oncology Society, International

Affiliation

Dr. Hartner is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.

Research

Selected Publications:

Ogilvie CM, Crawford EA, Slotcavage RL, King JJ, Lackman RD, Hartner L, Staddon AP: Treatment of Adult Rhabdomyosarcoma Am. J. Clin. Oncol. 33 : 128-131,2010.

Mintzer DM, Granda-Cameron C, Tobin B, Marcone D, Lynch MP, Hartner L., Staddon A: Embedding Palliative Care and Geriatric Oncology within a Private Oncology Practice Community Oncology : 331-334,2009.

Staddon A, Crawford EA, hartner L, Lackman RD, Ogolvie CM: Treatment of Metastatic Sarcomatoid Carcinoma with Doxorubicin and Ifoxamide ASCP Proccedings : 2008.

Mintzer Dm, King JJ, Alavi A, Staddon AP, Lackman RD, Hartner L, Fox EJ, Ogilvie CM: Utility of PET scan in predicting chemotherapeutic response in soft tissue sarcoma patients ASCO Meeting : 2007.

Staddon AP, King JJ, Ogilvie CM, Hartner L, Fox EJ, Lackman RD: Treatment of adult rhabdomyosarcoma ASCO Meeting : 2007.

Hartner LP, Rosen L, Hensley M, Mendelson D, Staddon AP, Chow W, Kovalyov O, Ruka W, Skladowski K, Byakhov AM: Phase 2 dose multi-center, open lable study of ARQ 501, a checkpoint activator in adults with persistent, recurrent or metastic leimyosarcoma (LMS) ASCO Meeting : 2007.

McCaffrey TA, Du B, Consigli S, Szabo P, Bray P, Hartner L, Weksler B, Sanborn TA, bergman G, Bush HL: Genomic Instability in the Type II TGF?1 Receptor Gene in Atherosclerotic and Restenotic Vacular Cells J. Clin. Invest. 100 : 2182-2188,1997.

Academic Contact Info

Pennsylvania Hematology Oncology at Pennsylvania Hospital
230 West Washington Square, 2nd Floor

Philadelphia, PA 19106
Phone: (215) 829-6088
Fax: (215) 829-6104
Patient appointments: 800-789-PENN (7366)

Related Links